Magaldrate

DB08938ApprovedInvestigationalWithdrawnSmall moleculeAntacids

Magaldrate is an antacid used to treat various conditions in the GI tract, such as esophagitis, duodenal and gastric ulcers, and gastroesophageal reflux. Magaldrate has been discontinued in the US market.

Formula / weight: Al₅H₃₃Mg₁₀O₄₀S₂ · 1115.3 g/mol (avg)
First approval: Canada, 1993
Also known as: Aluminium magnesium hydroxide sulfate hydrate · Aluminum magnesium hydroxide sulfate hydrate · Aluminum magnesium hydroxide sulphate hydrate · Hydrate magnesium aluminate activated sulfate · Magnesium aluminate hydrate
Code names: AY-5710

Resolves to

Compound

UNII6V88E24N5TCAS74978-16-8ChEMBLCHEMBL3833350ChEBI755940PubChem122706784KEGGD04832

Clinical / RWD

RxNorm29151ATCA02AD02ATCA02AF01

Structure

InChIKeySPPNVMTVMQOKSC-UHFFFAOYSA-ASMILES

O.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Mg++].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O

What you can answer from here — as of September 23, 2026

413Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

5Structured indicationsCondition, population, route and combination as fields, not prose

62Marketed productsAcross 9 countries and 20 labellers

2ATC codesIncluding every combination product, plus 16 drug categories

2+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Magaldrate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account